Clinical trials
Terminated Sarcoma, Ewing trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 2 |
| National Cancer Institute (NCI) | 2 |
| 3B Pharmaceuticals GmbH | 1 |
| AeRang Kim | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| Children's Oncology Group | 1 |
| Gradalis, Inc. | 1 |
| Incyte Corporation | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Ewing | 21 |
| Sarcoma | 10 |
| Rhabdomyosarcoma | 9 |
| Neuroblastoma | 8 |
| Neoplasms | 7 |
| Osteosarcoma | 7 |
| Wilms Tumor | 5 |
| Bone Neoplasms | 4 |
| Medulloblastoma | 4 |
| Neuroectodermal Tumors, Primitive, Peripheral | 4 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.